Kaliberr Bioscience Private Limited
About Kaliberr Bioscience Private Limited
Data last updated:
Kaliberr Bioscience Private Limited is a private limited company based in Nashik, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 May 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2020PTC339937. Its GSTIN is 27AAICK0882H1ZC (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Madhu Ramadugu and Madhusudan Ramratan Bhandari.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Nashik, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹46.04 Cr, a growth of 101% compared to the previous year. For the same year it recorded a net profit of ₹3.32 Cr (net margin 7.2%) and EBITDA of ₹8.65 Cr (EBITDA margin 18.8%).
The company has about 84 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Kaliberr Labs. As per MCA filings, the company has open charges of ₹32.3 Cr on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressShop No. 409 And 410 4th Floor Business World, Survey Number 798/2/4/5 Plot No 4/5 Govind Nagar Link Road, Nashik, Maharashtra, India – 422009
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Kaliberr Bioscience Private Limited
The main business activity of Kaliberr Bioscience is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Kaliberr Bioscience Private Limited FY 2024 filings available
Kaliberr Bioscience Private Limited reported revenue of ₹46.04 Cr (up 101% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Kaliberr Bioscience Private Limited
Revenue rose 101% in the latest year. EBITDA rose 79% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Kaliberr Bioscience Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹8.65 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3.32 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Kaliberr Bioscience Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 18.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 7.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Kaliberr Bioscience are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Kaliberr Bioscience Private Limited
Kaliberr Bioscience Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Brilliant Lifesciences Private Limited | ₹46.12 Cr (FY 2025) | •••• | •••• | 103.0% | •••• | Detroj, Gujarat, India |
| Abhilasha Pharma Private Limited | ₹46.09 Cr (FY 2025) | •••• | •••• | -2.0% | •••• | Ahmedabad, Gujarat, India |
| Kimberlite Chemicals (India) Private Limited | ₹46.07 Cr (FY 2024) | •••• | •••• | 0.0% | •••• | Doddaballapura, Karnataka, India |
| Aumgene Biosciences Private Limited | ₹46.06 Cr (FY 2025) | •••• | •••• | 37.0% | •••• | Surat, Gujarat, India |
| Dee Bee Organics Pvt. Ltd | ₹46.05 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Alwar, Rajasthan, India |
| Kaliberr Bioscience Private Limited this company | ₹46.04 Cr (FY 2025) | •••• | •••• | 101.0% | •••• | Nashik, Maharashtra, India |
| R L Chemical Industries Private Limited | ₹45.99 Cr (FY 2025) | •••• | •••• | -12.0% | •••• | Mumbai, Maharashtra, India |
| Omkar Speciality Chemicals Limited Listed | ₹45.98 Cr (FY 2021) | •••• | •••• | -20.0% | •••• | Badlapur, Maharashtra, India |
| Maithili Life Sciences Private Limited | ₹45.89 Cr (FY 2023) | •••• | •••• | 20.0% | •••• | Hyderabad, Telangana, India |
| Lucent Biotech Limited | ₹45.89 Cr (FY 2024) | •••• | •••• | 69.0% | •••• | Lucknow, Uttar Pradesh, India |
| Acaricide India Private Limited | ₹45.84 Cr (FY 2018) | •••• | •••• | -35.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Kaliberr Bioscience by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Kaliberr Bioscience Private Limited
Kaliberr Bioscience Private Limited is audited by UPENDRA MEHTA & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| UPENDRA MEHTA & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Kaliberr Bioscience Private Limited
Kaliberr Bioscience has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Madhu Ramadugu Also directs: Velvet and Vintage Hospitality LLP, Wellocity Bio Sciences Private Limited, Indigo Health Care Private Limited and 4 more | Director | 18 Jun 2020 | 6 Years 3 Months | Current |
| Madhusudan Ramratan Bhandari Also directs: Kaliberr Labs Private Limited | Director | 23 May 2020 | 6 Years 4 Months | Current |
| Sushant Madhusudan Bhandari Also directs: Kaliberr Labs Private Limited | Director | 23 May 2020 | 6 Years 4 Months | Current |
Ownership and Shareholding of Kaliberr Bioscience Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Kaliberr Bioscience Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Jul 2025 | Others | ₹79.89 Lakh | Open |
| 17 Jul 2023 | Hdfc Bank Limited | ₹14 Cr | Open |
| 20 Jun 2022 | Hdfc Bank Limited | ₹17.5 Cr | Open |
Total charge records: 3 View all charges
Associated Brands with Kaliberr Bioscience Private Limited
Kaliberr Bioscience operates one associated brand: Kaliberr Labs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing of general injectables and finished formulations in India. | kaliberrlabs.com |
Employees and EPFO Compliance at Kaliberr Bioscience Private Limited
Kaliberr Bioscience Private Limited has a workforce of 84 employees as of Apr 05, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Kaliberr Bioscience Private Limited
Kaliberr Bioscience Private Limited has 6 board changes on record since 2020: 3 appointments and 3 cessations. The latest: Prakash Gangadharan ceased to be Additional Director on 30 Sep 2023.
2 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Kaliberr Bioscience Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Kaliberr Bioscience Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Kaliberr Bioscience Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Kaliberr Bioscience Private Limited
Kaliberr Bioscience has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICK0882H1ZC | Maharashtra | Active | 30 Jun 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Kaliberr Bioscience Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kaliberr Bioscience Private Limited
Kaliberr Bioscience is an active private limited company based in Nashik, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 May 2020 (6+ years old) and is registered under CIN U24230MH2020PTC339937.
Kaliberr Bioscience reported revenue of ₹46.04 Cr for FY 2025 (up 101% YoY).
Kaliberr Bioscience has 3 current directors:
- Madhu Ramadugu - Director
- Madhusudan Ramratan Bhandari - Director
- Sushant Madhusudan Bhandari - Director
Kaliberr Bioscience reported a net profit of ₹3.32 Cr (net margin 7.2%) and EBITDA of ₹8.65 Cr (EBITDA margin 18.8%) for FY 2025, as per its filed financial statements.
The GSTIN of Kaliberr Bioscience is 27AAICK0882H1ZC, registered in Maharashtra.
The CIN (Corporate Identification Number) of Kaliberr Bioscience is U24230MH2020PTC339937. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kaliberr Bioscience was incorporated on 23 May 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Kaliberr Bioscience by revenue are Brilliant Lifesciences Private Limited, Abhilasha Pharma Private Limited, Kimberlite Chemicals (India) Private Limited, Aumgene Biosciences Private Limited, Dee Bee Organics Pvt. Ltd and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Prakash Gangadharan ceased to be Additional Director on 30 Sep 2023. Pavan Kumar Gorukanti ceased to be Director on 27 Aug 2022. Phalgun Gorukanti ceased to be Director on 27 Aug 2022. Kaliberr Bioscience has 6 board changes on record in total.
The registered office of Kaliberr Bioscience is at Shop No. 409 And 410 4th Floor Business World, Survey Number 798245 Plot No 45 Govind Nagar Link Road, Nashik, Maharashtra, India – 422009.
Kaliberr Bioscience has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh.